Efficacy trial of continuous ingestion of plant derived ingredients. [trial number g2018006]

Efficacy trial of continuous ingestion of plant derived ingredients. [trial number g2018006] - Efficacy of plant derived ingredients. [trial number g2018006]

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034129

Enrollment

Registered

2018-09-20

Start date

2018-09-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Control food A, once daily, continuous ingestion for 4 weeks Test food B, once daily, continuous ingestion for 4 weeks

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) Healthy male adults aged 20 and older, under 65 (2) Subjects with fasting glucose ranged 100 mg/dL and more, less than126 mg/dL (3) Subjects can consume test foods, and record life diaries and meal diaries (4) Subjects who have given written informed consent prior to study

Exclusion criteria

Exclusion criteria: (1)Subjects diagnosed with diabetes, or taking drugs related diabetes (2)Subjects who have history or symptom of cardiovascular disease or cerebrovascular disease (3)Subjects who have symptom of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (4)Subjects who have a history of resection of gastrointestinal tract, excluding cecal resection surgery (5)Heavy drinker (over 30g alcohol per day) (6)Subjects who have donated over 200 mL of blood within the last one month prior to the current study or over 400 mL of blood within the last three months prior to the study (7)Subjects who have severe anemia (Hb <=7g/dL) (8)Subjects who have food allergies for test foods (9)Subjects who plan to participate in other clinical study during the current study (10)Subjects who are judged to be inappropriate for the study by the medical doctor or investigator for other reasons

Design outcomes

Primary

Measure	Time frame
Blood glucose	—

Secondary

Measure	Time frame
Insulin, glucagon, 1.5-AG, glycol-albumin, gastrointestinal hormone, triglyceride, free fatty acids, apo B48, ketone body, body weight, body fat ratio, appetite (questionnaire)	—

Countries

Japan

Contacts

Public ContactMasanobu Hibi

Kao Corporation Biological Science Research laboratories

hibi.masanobu@kao.com03-5630-7266

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026